Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online September 5, 2007
Diabetes 56:2872-2877, 2007
DOI: 10.2337/db07-0115
© 2007 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online-Only Appendix
Right arrow All Versions of this Article:
db07-0115v1
56/12/2872    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cabou, C.
Right arrow Articles by Burcelin, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cabou, C.
Right arrow Articles by Burcelin, R.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Central Insulin Regulates Heart Rate and Arterial Blood Flow

An Endothelial Nitric Oxide Synthase–Dependent Mechanism Altered During Diabetes

Cendrine Cabou1,2, Patrice D. Cani1,3, Gérard Campistron1,2, Claude Knauf1, Caroline Mathieu4, Claudio Sartori4, Jacques Amar5, Urs Scherrer4, and Rémy Burcelin1

1 Inserm U858, Institute of Molecular Medicine I2MR, Toulouse, France
2 Faculty of Pharmacy, Paul Sabatier University, Toulouse, France
3 Unit of Pharmacokinetics, Metabolism, Nutrition, and Toxicology, PMNT-73/69, Université catholique de Louvain, Brussels, Belgium
4 Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
5 Inserm U558, Toulouse, France

Address correspondence and reprint requests to Rémy Burcelin, Inserm U858, Institute of Molecular Medicine, IFR31, CHU Rangueil, BP 84225, 31432 Toulouse Cedex 4, France. E-mail: burcelin{at}toulouse.inserm.fr

Abbreviations: aCSF, artificial cerebrospinal fluid; ANS, autonomic nervous system; eNOS, endothelial nitric oxide synthase; icv, intracerebroventricular; L-NMMA, NG-monomethyl-L-arginine; SIN-1, 3-morpholino sydnonimine

OBJECTIVE—Central neural insulin regulates glucose homeostasis, but less is known about its cardiovascular effects. Endothelial nitric oxide synthase (eNOS)-derived nitric oxide (NO) represents a molecular link between metabolic and cardiovascular disease. Its role in the central nervous system remains to be determined. We studied the effects of central insulin infusion on femoral arterial blood flow and heart rate in normal chow–fed, high-fat diet–fed diabetic, and eNOS-null mice.

RESEARCH DESIGN AND METHODS —We recorded heart rate and femoral blood flow (ultrasonic flow probe) during 3-h central insulin infusion in conscious, freely moving mice. To study the role of NO in this setting, we assessed total and phosphorylated eNOS in the hypothalamus and examined the effects of brain infusion of NO donors/NOS inhibitors on cardiovascular responsiveness to central insulin in these experimental mouse models.

RESULTS —In normal mice, central insulin rapidly increased heart rate by 30% and more progressively increased blood flow by 40%. In high-fat diet–fed mice, the cardiovascular effects of insulin were blunted and associated with a 50% reduction of the total and phosphorylated eNOS expression in the hypothalamus, suggesting a causal link. In line with this hypothesis, in eNOS-null mice and central NG-monomethyl-L-arginine–infused normal mice, the cardiovascular effects of insulin were abolished, whereas central NO donor infusion restored these effects in eNOS-null mice. In high-fat diet–fed mice, central NO donor infusion mimicked the cardiovascular responses evoked by central insulin in normal mice.

CONCLUSIONS —Central insulin has cardiovascular effects in conscious, freely moving mice that are mediated, at least in part, by central neural eNOS. These effects are impaired in insulin-resistant high-fat diet–fed mice.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
C. Cabou, G. Campistron, N. Marsollier, C. Leloup, C. Cruciani-Guglielmacci, L. Penicaud, D. J. Drucker, C. Magnan, and R. Burcelin
Brain Glucagon-Like Peptide-1 Regulates Arterial Blood Flow, Heart Rate, and Insulin Sensitivity
Diabetes, October 1, 2008; 57(10): 2577 - 2587.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.